____ BGI COWIN, established in 2016, focuses on biotech, biopharma, and medtech. formed in collaboration with BGI Group, a leading life science and genomics company. Their investment philosophy emphasizes 'R&D driven investment' and actively maps the industry to strategically invest in gene technology, medical devices, and biopharmaceuticals.The firm aims to help its portfolio companies realize their strategic and commercial potential by providing services in legal, finance management, and human resources. They mainly invest in start-up and growth phase projects, ensuring reasonable allocation during the investment phase. They leverage resources from BGI Group and notable research institutions to enhance operational management capabilities of their projects, promoting sustainable development and mutual benefits.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions